As of December 31, 2022, GIBH has undertaken more than 1,800 scientific research projects of the Ministry of Science and Technology of the People’s Republic of China, the Chinese Academy of Sciences, the National Natural Science Foundation of China, and local governments; moreover, it has published 2,147 scientific papers including 1,977 SCI papers, and submitted 846 patent applications, of which there is 634 domestic patents, 131 international patents and 81 PCT applications. The total number of granted applications is 422, including 370 domestic patents and 52 international ones. The invention patent "A method for establishing a model of immunodeficiency mouse" won the 19th China Patent Excellence Award and the 4th Guangdong Patent Excellence Award; the invention patent "Integrative plasmid pOPHI and resistance screening marker-free self-luminescent mycobacterium" won the 5th Guangdong Patent Excellence Award. In total, GIBH has won 2 second prizes of National Natural Science Award, 1 Outstanding Science and Technology Achievement Prize of Chinese Academy of Sciences, 2 Nanyue Innovation Award, 6 first prizes of Guangdong Science and Technology Award, 3 first prizes of Guangzhou Science and Technology Award, 1 China Patent Excellence Award and 3 Guangdong Patent Excellence Awards.
